Search
Vor Biopharma Inc
VORAdd to Watchlist
20.590USD
+2.200+11.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.12BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+11.96%
5 Days
+42.20%
1 Month
+41.32%
6 Months
+57.42%
Year to Date
+57.42%
1 Year
-28.01%
Key Figures
18.720Open
22.220High
3.37MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
6.22%Turnover Ratio
18.390Prev. Close
18.672Low
48.51MTurnover
LossP/E Static
-7.42P/B
0.00%Div Yield TTM
-286.69%ROA
65.80052wk High
2.24Volume Ratio
-116.91MNet Profit
54.19MShares
-70.4017EPS TTM
1.72Beta
-125.43%ROE
3.38452wk Low
19.29%Amplitude
--Gross Margin
1.12BMarket Cap
5.04Reward/Risk
6.87%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Vor Biopharma Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Vor Biopharma Inc Info
Vor Biopharma Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.
Ticker SymbolVOR
CompanyVor Biopharma Inc
CEOKress (Jean-Paul)
Websitehttps://www.vorbio.com/
Related Instruments
+1.33%
+2.83%
+5.32%
+3.44%
+2.26%
+3.06%
+3.01%
+2.95%
+3.47%
+1.82%
+4.20%
+1.56%
+3.97%
+3.16%
+2.05%
0.00%
+3.30%
+3.10%
+0.25%
+4.50%Popular Instruments
52753.900
+499.600 (+0.96%)
29257.200
-542.100 (-1.82%)
7464.100
-11.400 (-0.15%)
14763.000
-592.000 (-3.85%)
67909.000
-1576.000 (-2.27%)
6350.300
+74.900 (+1.19%)
68.354
+0.386 (+0.57%)
308.310
+13.930 (+4.73%)
193.510
-4.070 (-2.06%)
4117.350
+86.580 (+2.15%)
FAQs
What is the current price of Vor Biopharma Inc (VOR)?
The current price of Vor Biopharma Inc (VOR) is 18.39.
What is the symbol of Vor Biopharma Inc?
The ticker symbol of Vor Biopharma Inc is VOR.
What is the 52-week high of Vor Biopharma Inc?
The 52-week high of Vor Biopharma Inc is 65.80.
What is the 52-week low of Vor Biopharma Inc?
The 52-week low of Vor Biopharma Inc is 3.38.
What is the market capitalization of Vor Biopharma Inc?
The market capitalization of Vor Biopharma Inc is 996.48M.
Is Vor Biopharma Inc (VOR) currently rated as Buy, Hold, or Sell?
According to analysts, Vor Biopharma Inc (VOR) has an overall rating of Buy, with a price target of 37.88.
What is the Earnings Per Share (EPS TTM) of Vor Biopharma Inc (VOR)?
The Earnings Per Share (EPS TTM) of Vor Biopharma Inc (VOR) is -70.50.